🔎 Trials Near Me

Pradžia › LOPSL › Merilendas › Baltimore

LOPSL klinikiniai tyrimai Baltimore, MD

14 tyrimai dėl LOPSL ieško dalyvių vietose Baltimore ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Renkami dalyviai3 fazė
  • Johns Hopkins Bayview Medical Center- Site Number : 8400076, Baltimore
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07190222

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Renkami dalyviai4 fazė
  • Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07053423

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Renkami dalyviai2 fazė
  • Research Site, Baltimore
  • Research Site, Baltimore
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Renkami dalyviai2 fazė
  • Johns Hopkins University, Baltimore
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Renkami dalyviai3 fazė
  • Research Site, Baltimore
  • Research Site, Rosedale · už 6 mylių
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Renkami dalyviai3 fazė
  • Research Site, Baltimore
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06883305

STRIVE Post-Market Registry Study

Renkami dalyviaiStebimasis tyrimas
  • University of Maryland, Baltimore
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-03 · NCT04302272

Multi-Center Clean Air Randomized Controlled Trial in COPD

Renkami dalyviai3 fazė
  • University of Maryland, Baltimore
  • Johns Hopkins, Baltimore
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-07-31 · NCT06376994

SPIROMICS Study of Early COPD Progression (SOURCE)

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
  • Johns Hopkins Bayview Medical Center, Baltimore
Amžius nuo 30 iki 55 · Visoms lytims · Atnaujinta 2026-06-03 · NCT05033990

OMEGA - Dietary Intervention - COPD Trial

Renkami dalyviai
  • Johns Hopkins Bayview Campus, Baltimore
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-03-16 · NCT05297279

Trial to Determine Effective Aspirin Dose in COPD

Renkami dalyviai3 fazė
  • Johns Hopkins Bayview Medical Center, Baltimore
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-03-16 · NCT05265299

Effectiveness of the WearME System for COPD Severity and Respiratory Function

Renkami dalyviaiStebimasis tyrimas
  • Johns Hopkins, Baltimore
Amžius nuo 21 iki 100 · Visoms lytims · Atnaujinta 2025-09-09 · NCT06751537

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Renkami dalyviaiStebimasis tyrimas
  • Ascension St. Agnes Hospital, Baltimore
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2025-08-05 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Renkami dalyviai
  • University of Maryland - Baltimore, Baltimore
Amžius 30 ir vyresni · Visoms lytims · Atnaujinta 2025-02-06 · NCT05204888

LOPSL tyrimai kituose miestuose

Kiti tyrimai Baltimore

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.